Lung Surfactants Market: Trends, Forecast, and Competitive Landscape 2025 -2032

This Lung Surfactants Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics, and insights about new geographical markets. The market insights covered in Electric Enclosure report simplifies managing marketing of goods and services effectively.

Data Bridge Market Research analyses that the lung surfactants market was valued at USD 173 million in 2021 and is expected to reach USD 242.28 million by 2029, registering a CAGR of 4.30% during the forecast period of 2022 to 2029.

Download Sample PDF Copy of this Report to understand structure of the complete report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-surfactants-market

Market Overview:

Lungs surfactants are administered to prevent and treat neonatal respiratory distress syndrome (RDS). RDS is a serious consequence of premature delivery that affects over 40,000 infants in the United States and Canada every year. The lungs eventually collapse due to low lung compliance caused by a functional or quantitative surfactant deficit. Surfactant, a mixture of phospholipids, neutral lipids, and proteins created by pneumocytes during pregnancy, lowers surface tension and thereby stabilizes alveoli, increasing lung compliance and reducing shortness of breath.

Some of the major players operating in the Lung Surfactants Market are

CHIESI Farmaceutici S.p.A. (Italy), ONY Biotech Inc. (U.S.), Lyomark Pharma GmbH (Germany), Windtree Therapeutics, Inc (U.S.), Aviva Systems Biology Corporation (U.S.), Boehringer Ingelheim International GmbH. (Germany), AbbVie Inc. (U.S.), Abbott (U.S.)



Global Lung Surfactants Market Scope

The lung surfactants market is segmented on the basis of indication, drug, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

Respiratory Distress Syndrome (RDS)
Respiratory Infections
Others
Drugs

Poractant
Beractant
Lucinactant
Calfactant
Others
Route of Administration

Intratracheal
Injectable
End-Users

Hospitals
Specialty Clinics
Homecare
Others
Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-lung-surfactants-market

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Lung Surfactants Market

Part 04: Global Lung Surfactants Market Sizing

Part 05: Global Lung Surfactants Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Browse Trending Reports:

https://trendmarketinsights.blogspot.com/2025/01/solar-pump-market-industry-trends-and.html

https://trendmarketinsights.blogspot.com/2025/01/angiography-devices-market-size-share.html

https://trendmarketinsights.blogspot.com/2025/01/tire-material-market-industry-trends.html

Data Bridge Market Research

US: +1 888 387 2818

United Kingdom: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: - sopan.gedam@databridgemarketresearch.com

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

This release was published on openPR.